PSA
56
3
FOXA
52
-14
RHI
57
-6
IFF
47
-4
GE
61
-3
D
40
2
FAST
57
-3
DHR
32
-6
JNPR
50
-6
F
56
-3
CMI
64
-3
RIG
43
-7
VRTX
47
-6
ECL
55
-2
WEC
53
5
NWSA
62
-7
PLD
45
-5
DGX
48
11
CAT
59
-2
URI
60
-6
PSA
56
3
FOXA
52
-14
RHI
57
-6
IFF
47
-4
GE
61
-3
D
40
2
FAST
57
-3
DHR
32
-6
JNPR
50
-6
F
56
-3
CMI
64
-3
RIG
43
-7
VRTX
47
-6
ECL
55
-2
WEC
53
5
NWSA
62
-7
PLD
45
-5
DGX
48
11
CAT
59
-2
URI
60
-6
Financhill
Back

iShares CMBS ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
36

CMBS
iShares CMBS ETF

Last Price:
47.27
Seasonality Move:
0.72%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
36
iShares CMBS ETF (CMBS) is a Sell

Is iShares CMBS ETF a Buy, Sell or Hold?

  • The current iShares CMBS ETF [CMBS] share price is $47.24. The Score for CMBS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CMBS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CMBS Stock Price Chart

What is iShares CMBS ETF's stock price today?

  • The iShares CMBS ETF share price today is $47.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMBS is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CMBS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 38.63 Sell
Chaikin Money Flow: 797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.3 - 47.84) Sell
Bollinger Bands (100): (47.25 - 48.43) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CMBS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.31 Sell
20-day SMA: 47.47 Sell
50-day SMA: 48.06 Sell
200-day SMA: 47.21 Buy
8-day EMA: 47.31 Sell
20-day EMA: 47.49 Sell
50-day EMA: 47.76 Sell
200-day EMA: 47.31 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares CMBS ETF Earnings Growth & CMBS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares CMBS ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):